Abstract
There are no methods available for the direct determination of the concentration of noradrenaline in the “biophase”, i.e., in the very small part of the extracellular space in the immediate neighbourhood of the receptors of adrenergically innervated organs. Hence, any discussion of the factors influencing the concentration of the amine at the receptors has to be based on indirect evidence. If the direct approach is impossible, one can gain some insight from recording responses (or changes in responses) of the effector organ to known concentrations of noradrenaline. However, any interpretation involves two crucial assumptions, namely that, in the absence of conclusive evidence to the contrary, the interaction between drug and receptor as well as the function of the link between receptor activation and eventual response remains unaffected by the change in experimental conditions which is being studied. In many experimental situations the validity of these assumptions remains questionable, since it has not been possible to obtain positive evidence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acheson, G.H.: The topographical anatomy of the smooth muscle of the cat’s nictitatingmembrane. Anat. Rec. 71, 297–311 (1938).
Almgren, O., Anden, N.-E., Jonason, J., Norberg, K.-A., Olson, L.: Cellular localizationof monoamine oxidase in rat salivary glands. Acta physiol. scand. 67, 21–26 (1966).
Anden, N.-E., Corrodi, H., Ettles, M., Gustafsson, E., Persson, H.: Selective uptake of some catecholamines by the isolated heart and its inhibition by cocaine and phenoxy-benzamine. Acta pharmacol. (Kbh.) 21, 247–259 (1964).
Antonaccio, M. J., Smith, C. B.: Effects of chronic pretreatment with pargyline upon responses of the atrial pacemaker and of left atrial strips of guinea pigs to tyramine, mephentermine, d-amphetamine and adrenergic nerve stimulation. J. Pharmacol, exp. Ther. 170, 97–107 (1969).
Avakian, O.V., Gillespie, J.S.: Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response. Brit. J. Pharmacol. 32, 168–184 (1968).
Bacq, Z.M., Renson, J.: Actions et importance physiologique de la metanephrine et de lanormetanephrine. Arch. int. Pharmacodyn. 130, 385–402 (1961).
Balzer, H., Holtz, P.: Beeinflussung der Wirkung biogener Amine durch Hemmung der Aminoxydase. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 227, 547–558 (1956).
Bell, C.: Effects of cocaine and of monoamine oxidase and catechol-O-methyl transferase inhibitors on transmission to the guinea-pig vas deferens. Brit. J. Pharmacol. 31, 276–289 (1967).
Bennet, M.R., Rogers, D.C.: A study of the innervation of the taenia coli. J. Cell Biol. 33, 573–596 (1967).
Bevan, J. A., Verity, M.A.: Sympathetic nerve-free vascular muscle. J. Pharmacol, exp.Ther. 157, 117–124 (1967).
Bhagat, B., Bovell, G., Robinson, I.M.: Influence of cocaine on the uptake of H3-nor-epinephrine and on the responses of isolated guinea-pig atria to sympathomimetic amines. J. Pharmacol, exp. Ther. 155, 472–478 (1967).
Bickerton, R.K.: The response of isolated strips of cat spleen to sympathomimetic drugs andtheir antagonists. J. Pharmacol, exp. Ther. 142, 99–110 (1963).
Birmingham, A.T.: Sympathetic denervation of the smooth muscle of the vas deferens. J.Physiol. (Lond.) 206, 645–661 (1970).
Blinks, J.R.: Evaluation of the cardiac effects of several beta adrenergic blocking agents. Ann. N.Y. Acad. Sci. 139, 673–685 (1967).
Bonaccorsi, A., Jespersen, J., Garattini, S.: The influence of desipramine on the sensitivity and accumulation of noradrenaline in the isolated tail artery of the rat. Europ. J. Pharmacol. 9, 124–127 (1970).
Brimijoin, S., Pluchino, S., Trendelenburg, U.: On the mechanism of supersensitivity to norepinephrine in the denervated cat spleen. J. Pharmacol, exp. Ther. 175, 503–513 (1970).
Brody, M.J.: Cardiovascular responses following immunological sympathectomy. Circulat.Res. 15, 161–167 (1964).
Brown, G.L., Gillespie, J.S.: The output of sympathetic transmitter from the spleen of thecat. J. Physiol. (Lond.) 138, 81–102 (1957).
Burford, H., Leick, J., Walaszek, E.J.: Modification of the effects of biogenic amines onthe heart by iproniazid. Arch. int. Pharmacodyn. 128, 39–50 (1960).
Cervoni, P., Reit, E., Mccullough, J.: Studies on the decentralized nictitating membrane of the cat. II. Uptake and retention of norepinephrine and epinephrine. J. Pharmacol, exp. Ther. 175, 649–663 (1970).
Chahl, L.A., O’Donnell, S.R.: The interaction of cocaine and propranolol with catecholamines on guinea pig trachea. Europ. J. Pharmacol. 2, 77–82 (1967).
Clarke, D.E., Jones, C.J., Linley, P.A.: Histochemical fluorescence studies on noradrenaline accumulation by uptake in the isolated rat heart. Brit. J. Pharmacol. 37, 1–9 (1969).
Crout, J. R.: Effect of inhibiting both catechol-O-methyl transferase and monoamine oxidase on cardiovascular responses to norepinephrine. Proc. Soc. exp. Biol. (N.Y.) 108, 482–484 (1961).
De La Lande, I.S., Frewin, D., Waterson, J.G.: The influence of sympathetic innervation on vascular sensitivity to noradrenaline. Brit. J. Pharmacol. 31, 82–93 (1967).
De La Lande, I.S., Jellett, L.B.: Relationship between the roles of monoamine oxidase and sympathetic nerves in the vasoconstrictor response of the rabbit ear artery to noradrenaline. J. Pharmacol. exp. Ther. (in press) (1971).
De La Lande, I.S., Waterson, J. G.: Site of action of cocaine on the perfused artery. Nature (Lond.) 214, 313–314 (1967).
Drasköczy, P.R., Trendelenburg, U.: The uptake of 1-and d-norepinephrine by the isolated perfused rabbit heart in relation to the stereospecificity of the sensitizing action of cocaine. J. Pharmacol, exp. Ther. 159, 66–73 (1968).
Drasköczy, P.R., Trendelenburg, U.: Intraneuronal And Extraneuronal Accumulation Of Sympathomimetic Amines In Theisolated Nictitating Membrane Of The Cat. J. Pharmacol, Exp. Ther. 174, 290–306 (1970).
Ehinger, B., Falck, B., Sporrong, B.: Adrenergic fibers to the heart and to peripheral vessels. Bibl. anat. (Basel) 8, 35–45 (1967).
Eisenfeld, A. J., Axelrod, J., Krakoff, L.: Inhibition of the extraneuronal accumulation and metabolism of norepinephrine by adrenergic blocking agents. J. Pharmacol, exp. Ther. 156, 107–113 (1967a).
Eisenfeld, A. J., Landsberg, L., Axelrod, J.: Effect of drugs on the accumulation and metabolism of extra-neuronal norepinephrine in the rat heart. J. Pharmacol, exp. Ther. 158, 378–385 (1967b).
Emmelin, N.: Supersensitivity following “pharmacological denervation”. Pharmacol. Rev. 13, 17–38 (1961).
Esterhuizen, A.C., Graham, J.D.P., Lever, J.D., Spriggs, T.L.B.: Catecholamine and acetylcholinesterase distribution in relation to noradrenaline release. An enzyme histo-chemical and autoradiographic study on the innervation of the cat nictitating membrane. Brit. J. Pharmacol. 32, 46–56 (1968).
Fleckenstein, A., Bass, H.: Zum Mechanismus der Wirkungsverstärkung und Wirkungs-abschwächung sympathomimetischer Amine durch Cocain und andere Pharmaka. I. Die Sensibilisierung der Katzen-Nickhaut für Sympathomimetica der Brenzkatechin-Reihe. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 220, 143–156 (1953).
Fleckenstein, A., Burn, J.H.: The effect of denervation on the action of sympathomimetic amines on the nictitating membrane. Brit. J. Pharmacol. 8, 69–78 (1953).
Fleckenstein, A., Stöckle, D.: Zum Mechanismus der WirkungsVerstärkung und Wirkungsabschwächung sympathomimetischer Amine durch Cocaine und andere Pharmaka. II. Die Hemmung der Neuro-Sympathomimetica durch Cocain. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 224, 401–415 (1955).
Fleming, W.W., Trendelenburg, U.: Development of supersensitivity to norepinephrine after pretreatment with reserpine. J. Pharmacol, exp. Ther. 133, 41–51 (1961).
Foster, R.W.: The potentiation of the responses to noradrenaline and isoprenaline of the guinea-pig isolated tracheal chain preparation by desipramine, cocaine, phentolamine, phenoxybenzamine, guanethidine, metanephrine and cooling. Brit. J. Pharmacol. 31, 466–482 (1967).
Foster, R.W.: A Correlation Between Inhibition Of The Uptake Of 3H From (±)–3H-Noradrenaline And Potentiation Of The Responses To (-)-Noradrenaline In The Guinea-Pig Isolated Trachea. Brit. J. Pharmacol. 33, 357–367 (1968).
Foster, R.W.: An Uptake Of Radioactivity From (+)–3H-Isoproterenol And Its Inhibition By Drugs Which Potentiate The Responses To (-)-Isoproterenol In The Guinea-Pig Isolated Trachea. Brit. J. Pharmacol. 35, 418–427 (1969).
Frey, H. H.: Monoamine oxidase inhibition and sensitivity of nictitating membrane to nor-adrenaline. Acta Pharmacol. (Kbh.) 20, 90–96 (1963).
Furchgott, R.F.: The pharmacological differentiation of adrenergic receptors. Ann. N.Y. Acad. Sci. 139, 553–570 (1967).
Furchgott, R.F., Kirpekar, S.M., Rieker, M., Schwab, A.: Actions and interactions of norepinephrine, tyramine and cocaine on aortic strips of rabbit and left atria of guinea pig and cat. J. Pharmacol, exp. Ther. 142, 39–58 (1963).
Furchgott, R.F., Sanchez-Garcia, P.: Effects of inhibition of monoamine oxidase on the actions and inter-actions of norepinephrine, tyramine and other drugs on guinea-pig left atrium. J. Pharmacol. exp. Ther. 163, 98–122 (1968).
Furchgott, R.F., Weinstein, Hebl, H., Bozorgmehri, P., Mensendiek, R.: Effect of inhibition of monoamine oxidase on response of rabbit aortic strips to sympathomimetic amines. Fed. Proc. 14, 341–342 (1955).
Furness, J.B.: The excitatory input to a single smooth muscle cell. Pflügers Arch, 314, 1–13 (1970).
Giles, R.E., Miller, J.W.: Studies on the potentiation of the inotropic actions of certain catecholamines by U-0521 (3’,4’-dihydroxy-a-methyl propiophenone). J. Pharmacol, exp. Ther. 157, 55–61 (1967).
Gillespie, J.S., Hamilton, D.N.H.: A possible active transport of noradrenaline into arterial smooth muscle cells. J. Physiol. (Lond.) 192, 30P (1967).
Gillespie, J.S., Hosie, R.J. A.: The extraneuronal uptake and localization of noradrenaline in the catspleen and the effect on this of some drugs, of cold and of denervation. J. Physiol. (Lond.) 206, 563–590 (1970).
Gillespie, J.S., Mum, T.C.: Species and tissue variation in extraneuronal and neuronal accumulation of noradrenaline. J. Physiol. (Lond.) 206, 591–604 (1970).
Govier, W.C., Sugrue, M.F., Shore, P.S.: On the inability to produce supersensitivity to catecholamines in intestinal smooth muscle. J. Pharmacol, exp. Ther. 165, 71–77 (1969).
Graefe, K.H., Bönisch, H., Trendelenburg, U.: Time-dependent changes in neuronal net uptake of noradrenaline after pretreatment with pargyline and/or reserpine. Naunyn-Schmiedeberg’s Arch. Pharmak. 271, 1–28 (1971).
Graefe, K.H., Trendelenburg, U.: The effect of cocaine on uptake of and sensitivity to noradrenaline in isolated nictitating membranes before and after storage in the cold. Naunyn-Schmiede-berg’s Arch. Pharmak. 267, 383–398 (1970).
Green, III, R.D., Fleming, W.W.: Agonist-antagonist interactions in the normal and supersensitive nictitating membrane of the spinal cat. J. Pharmacol, exp. Ther. 156, 207–214 (1967).
Green, III, R.D., Fleming, W.W.: Analysis Of Supersensitivity In The Isolated Spleen Of The Cat. J. Pharmacol, Exp. Ther. 162, 254–262 (1968).
Griesemer, E.C., Barsky, J., Dragstedt, C.A., Wells, A. J., Zeller, E.A.: Potentiating effect of iproniazid on the pharmacological action of sympathomimetic amines. Proc. Soc. exp. Biol. (N.Y.) 84, 699–701 (1953).
Haefely, W., Hürlimann, A., Thoenen, H.: A quantitative study of the effect of cocaine on the response of the cat nictitating membrane to nerve stimulation and to injected noradrenaline. Brit. J. Pharmacol. 22, 5–21 (1964).
Haeusler, G., Haefely, W., Thoenen, H.: Chemical sympathectomy of the cat with 6-hydroxydopamine. J. Pharmacol, exp. Ther. 170, 50–61 (1969).
Hamberger, B., Norberg, K.-A., Olson, L.: Extraneuronal binding of catecholamines and 3,4-dihydroxyphenylalanine (dopa) in salivary glands. Acta physiol. scand. 69, 1–12 (1967).
Hardman, J.G., Mayer, S.E., Clark, B.: Cocaine potentiation of the cardiac inotropic and Phosphorylase responses to catecholamines as related to the uptake of H3-catecholamines. J. Pharmacol, exp. Ther. 150, 341–348 (1965).
Hebb, C.O., Konzett, H.: Vaso-and bronchodilator effects of N-isopropylnorepinephrine in isolated perfused dog lungs. J. Pharmacol, exp. Ther. 96, 228–237 (1949).
Hertting, G.: The fate of 3H-isoproterenol in the rat. Biochem. Pharmacol. 13, 1119–1128 (1964).
Hertting, G., Suko, J., Widhalm, S., Harbich, I.: Uber den Mechanismus der Potenzierung der Kate-cholaminwirkung nach chronisch postganglionärer sympathischer Denervierung. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 256, 40–45 (1967).
Hollands, B.C.S., Vanov, S.: Localization of catechol amines in visceral organs and ganglia of the rat, guinea-pig and rabbit. Brit. J. Pharmacol. 25, 307–316 (1965).
Holman, M.E.: Electrophysiology of vascular smooth muscle. Ergebn. Physiol. 61, 137–177 (1969).
Hukoviö, S., Muscholl, E.: Die Noradrenalin-Abgabe aus dem isolierten Kaninchenherzen bei sympathischer Nervenreizung und ihre pharmakologische Beeinflussung. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 244, 81–96 (1962).
Innes, I.R., Kosterlitz, H.W.: The effects of preganglionic and postganglionic denervation on the responses of the nictitating membrane to sympathomimetic substances. J. Physiol. (Lond.) 124, 25–43 (1954).
Iversen, L.L.: The uptake of noradrenaline by the isolated perfused rat heart. Brit. J. Pharmacol. 21, 523–537 (1963).
Iversen, L.L.: The Uptake Of Catechol Amines At High Perfusion Concentrations In The Rat Isolated Heart: a novel catechol amine uptake process. Brit. J. Pharmacol. 25, 18–33 (1965).
Iversen, L.L.: The Uptake And Storage Of Noradrenaline In Sympathetic Nerves. Cambridge: University Press 1967.
Iversen, L.L., Langer, S.Z.: Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Brit. J. Pharmacol. 37, 627–637 (1969).
Iversen, L.L., Salt, P. J.: Inhibition of catecholamine uptake by steroids in the isolated rat heart. Brit. J. Pharmacol. 40, 528–530 (1970).
Izquierdo, J.A., Kaumann, A. J.: Effect of pyrogallol on the duration of the cardiovascular action of catecholamines. Arch. int. Pharmacodyn. 144, 437–445 (1963).
Jarrott, B.: Occurrence and properties of catechol-O-methyl transferase in adrenergic neurons. J. Neurochem. 18, 17–27 (1971).
Jarrott, B., Langer, S.Z.: Changes, in monoamine oxidase and catechol-O-methyl transferase activities after denervation of the nictitating membrane of the cat. J. Physiol. (Lond.) 212, 549–559 (1971).
Kalsner, S., Nickerson, M.: Disposition of phenylephrine in vascular tissue, determined by the oil-immersion technique. J. Pharmacol, exp. Ther. 163, 1–10 (1968).
Kalsner, S., Nickerson, M.: Disposition Of Norepinephrine And Epinephrine In Vascular Tissue, Determined By Thetechnique Of Oil Immersion. J. Pharmacol, Exp. Ther. 165, 152–165 (1969A).
Kalsner, S., Nickerson, M.: Mechanism Of Cocaine Potentiation Of Responses To Amines. Brit. J. Pharmacol. 35,428–439 (1969B).
Kasuya, Y., Goto, K.: The mechanism of supersensitivity to norepinephrine induced by cocaine in rat isolated vas deferens. Europ. J. Pharmacol. 4, 355–362 (1968).
Kaumann, A.J.: Adrenergic receptors in heart muscle: relations among factors influencing the sensitivity of the cat papillary muscle to catecholamines. J. Pharmacol, exp. Ther. 173, 383–398 (1970).
Kaumann, A.J.: Potentiation Of (-Isoproterenol And (-Norepinephrine By Hydrocortisone In Cat Heart Muscle. Acta Cient. Venez. 22, R–37 (1971).
Koch-Weser, J.: Direct and beta adrenergic receptor blocking actions of nethalide on isolated heart muscle. J. Pharmacol, exp. Ther. 146, 318–326 (1964).
Konzett, H.: Verstärkung der Wirkung von Isopropylnoradrenalin durch Pyrogallol. Arch, int. Pharmacodyn. 139, 558–563 (1962).
Kroneberg, G., Schlossmann, K., Haberland, G.: O-Methyltransferase-Hemmung in vitro und Adrenalin-Noradrenalin-Sensibilisierung in vivo. Naunyn-Schmiedeberg’s Arch, exp. Path. Pharmak. 241, 522 (1961).
Kukovetz, W.R., Lembeck, F.: Untersuchungen über die adrenalinpotenzierende Wirkung von Cocain und Denervierung. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 242, 467–479 (1962).
Langer, S.Z.: The degeneration contraction of the nictitating membrane in the unanesthetized cat. J. Pharmacol, exp. Ther. 151, 66–72 (1966a).
Langer, S.Z.: Presence Of Tone In The Denervated And In The Decentralized Nictitating Membrane Of The Spinal Cat And Its Influence On Determinations Of Supersensitivity. J. Pharmacol, Exp. Ther. 154,14–34 (1966B).
Langer, S.Z.: The Effects Of Phenoxybenzamine On Metabolism Of 3H-Noradrenaline Released From The Isolated Nictitating Membrane. Brit. J. Pharmacol. 34, 222P–223P (1968).
Langer, S.Z.: The Metabolism Of H3-Noradrenaline Released By Electrical Stimulation From The Isolated Nictitating Membrane Of The Cat And From The Vas Deferens Of The Rat. J. Physiol. (Lond.) 208, 515–546 (1970).
Langer, S.Z., Bogaert, M.G., De Schaepdryver, A.F.: Influence of metanephrine on responses of the nictitating membrane of the pithed cat to sympathomimetic amines. J. Pharmacol, exp. Ther. 157, 517–523 (1967a).
Langer, S.Z., Draskoczy, P.R., Trendelenburg, U.: Time course of the development of super-sensitivity to various amines in the nictitating membrane of the pithed cat after denervation or decentralization. J. Pharmacol, exp. Ther. 157, 255–273 (1967b).
Langer, S.Z., Trendelenburg, U.: The onset of denervation supersensitivity. J. Pharmacol, exp. Ther. 151, 73–86 (1966).
Langer, S.Z., Trendelenburg, U.: Decrease In Effectiveness Of Phenoxybenzamine After Chronic Denervation And Chronicdecentralization Of The Nictitating Membrane Of The Pithed Cat. J. Pharmacol, Exp. Ther. 163, 290–299 (1968).
Langer, S.Z., Trendelenburg, U.: The Effect Of A Saturable Uptake Mechanism On The Slopes Of Dose-Response Curves Forsympathomimetic Amines And On The Shifts Of Dose-Response Curves Produced By A Competitive Antagonist. J. Pharmacol, Exp. Ther. 167, 117–142 (1969).
Lembeck, F., Resch, H.: Die Potenzierung der Adrenalinwirkung durch Cocain und Pyro-gallol. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 240, 210–217 (1960).
Levin, J.A., Furchgott, R.F.: Interactions between potentiating agents of adrenergic amines in rabbit aortic strips. J. Pharmacol, exp. Ther. 172, 320–331 (1970).
Lightman, S.L., Iversen, L.L.: The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Brit. J. Pharmacol. 37, 638–649 (1969).
Lindmar, R., Muscholl, E.: Die Wirkung von Pharmaka auf die Elimination von Nor-adrenalin aus der Perfusionsflüssigkeit und die Noradrenalinaufnahme in das isolierte Herz. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak. 247, 469–492 (1964).
Löffelholz, K., Lindmar, R., Muscholl, E.: Analysis of wash-out of noradrenaline from the perfused rabbit heart after infusion of noradrenaline. Naunyn-Schmiedeberg’s Arch. Pharmak. 270, R87 (1971).
Maxwell, R.A., Plummer, A. J., Povalski, H., Schneider, F., Coombs, H.: A comparison of some of the cardiovascular actions of methylphenidate and cocaine. J. Pharmacol, exp. Ther. 126, 250–257 (1959).
Maxwell, R.A., Wastila, W.B., Eckhardt, S.B.: Some factors determining the response of rabbit aortic strips to dl-norepinephrine–7-H3 hydrochloride and the influence of cocaine, guanethidine and methylphenidate on these factors. J. Pharmacol, exp. Ther. 151, 253–261 (1966).
Mcneill, J.H., Brody, T.M.: The effect of various drug pretreatments on amine-induced phosphorylase activation and amine uptake. J. Pharmacol, exp. Ther. 162, 121–133 (1968).
Mcneill, J.H., Brody, T.M.: The Effect Of D-And 1-Norepinephrine On Rat Cardiac Phosphorylase Activation. J.Pharmacol, Exp. Ther. 165, 97–101 (1969).
Merrillees, N.C.R., Burnstock, G., Holman, M.E.: Correlation of fine structure and physiology of the innervation of smooth muscle in the guinea pig vas deferens. J. Cell Biol. 19, 529–550 (1963).
Muscholl, E.: Effect of cocaine and related drugs on the uptake of noradrenaline by heart and spleen. Brit. J. Pharmacol. 16, 352–359 (1961).
Pick, J.: Fine structure of nerve terminals in the human gut. Anat. Rec. 159, 131–138 (1967).
Plttchino, S.: Direct and indirect effects of 5-hydroxytryptamine and tyramine on cat smooth muscle. Naunyn-Schmiedebergs Arch. Pharmak. 272, 189–224 (1972).
Plttchino, S., Trendelenburg, U.: The influence of denervation and of decentralization on the alpha and beta effects of isoproterenol on the nictitating membrane of the pithed cat. J. Pharmacol. exp. Ther. 163, 257–265 (1968).
Plttchino, S., Van Orden, L.S., III., Draskegzy, P.R., Langer, S.Z., Trendelenburg, U.: The effect of beta-TMlO on the pharmacological, biochemical and morphological changes induced by denervation of the nictitating membrane of the cat. J. Pharmacol, exp. Ther. 172, 77–90 (1970).
Reiffenstein, R. J.: Effects of cocaine on the rate of contraction to noradrenaline in the cat spleen strip: mode of action of cocaine. Brit. J. Pharmacol. 32, 591–597 (1968).
Ross, S.B., Renyi, A.L.: Uptake of some tritiated sympathomimetic amines by mouse brain cortex slices in vitro. Acta pharmacol. (Kbh.) 24, 297–309 (1966).
Schmitt, H., Gonnard, P.: Modifications par un inhibiteur de l’aminoxydase, l’iproniazide, des effets de quelques amines sympathicomimetiques sur la membrane nictitante du chat. Arch. int. Pharmacodyn. 108, 74–83 (1956).
Schumann, H. J., Guther, W.: Untersuchungen zum Wirkungsmechanismus von Angiotensin am isolierten Aortenpraparat und am Blutdruck von Ratten und Meerschweinchen. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 256, 169–182 (1967).
Seidehamel, R.J., Patil, P.N., Tye, A., Lapidus, J.B.: The effects of norepinephrine isomers on various supersensitivities of the cat nictitating membrane. J. Pharmacol, exp. Ther. 153, 81–89 (1966).
Simmonds, M.A., Gillis, C.N.: Uptake of normetanephrine and norepinephrine by cocaine-treated rat heart. J. Pharmacol, exp. Ther. 159, 283–289 (1968).
Smith, C. B.: The role of monoaminoxidase in the intraneuronal metabolism of norepinephrine released by indirectly-acting sympathomimetic amines or by adrenergic nerve stimulation. J. Pharmacol, exp. Ther. 151, 207–220 (1966).
Smith, C. B., Trendelenburg, U., Langer, S.Z., Tsai, T.H.: The relation of retention of norepine-phrine-H3 to the norepinephrine content of the nictitating membrane of the spinal cat during development of denervation supersensitivity. J. Pharmacol, exp. Ther. 151, 87–94 (1966).
Somlyo, A. V., Woo, C. Y., Somlyo, A. P.: Responses of nerve free vessels to vasoactive amines and polypeptides. Amer. J. Physiol. 208, 748–753 (1965).
Stafford, A.: Potentiation of some catecholamines by phenoxybenzamine, guanethidine and cocaine. Brit. J. Pharmacol. 21, 361–367 (1963).
Suarne, L., Von Euler, U.S.: Stereospecificity of amine uptake mechanism in nerve granules. J. Pharmacol, exp. Ther. 150, 335–340 (1965).
Thoenen, H., Tranzer, J.P.: Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn-Schmiedeberg’s Arch. Pharmak. exp. Path. 261, 271–288 (1968).
Trendelenburg, U.: The supersensitivity caused by cocaine. J. Pharmacol, exp. Ther. 125, 55–65 (1959).
Trendelenburg, U.: The Action Of Acetylcholine On The Nicitating Membrane Of The Spinal Cat. J. Pharmacol, Exp. Ther. 135, 39–44 (1962).
Trendelenburg, U.: Supersensitivity And Subsensitivity To Sympathomimetic Amines. Pharmacol. Rev. 15, 225–276 (1963).
Trendelenburg, U.: Supersensitivity By Cocaine To Dextrorotatory Isomers Of Norepinephrine And Epinephrine. J, Pharmacol, Exp. Ther. 148, 329–338 (1965).
Trendelenburg, U.: Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol. Rev. 18, 629–640 (1966a).
Trendelenburg, U.: Supersensitivity To Norepinephrine Induced By Continuous Nerve Stimulation. J. Pharmacol. Exp. Ther. 151, 95–102 (1966B).
Trendelenburg, U.: The Effect Of Cocaine On The Pacemaker Of Isolated Guinea-Pig Atria. J. Pharmacol, Exp. Ther. 161, 222–231 (1968).
Trendelenburg, U.: Supersensitivity Of The Isolated Nictitating Membrane Of The Cat To Sympathomimetic Amines After Impairment Of The Intraneuronal Mechanisms Of Inactivation. Naunyn-Schmiedeberg’S Arch. Pharmak. 271, 29–58 (1971).
Trendelenburg, U., Draskoczy, P. R.: The effect of intraneuronal inactivation on the transmembranal uptake of 1-and d-norepinephrine. J. Pharmacol, exp. Ther. 175, 521–524 (1970).
Trendelenburg, U., Draskoczy, P. R., Pluchino, S.: The density of adrenergic innervation of the cat’s nictitating membraneas a factor influencing the sensitivity of the isolated preparation to 1-norepinephrine. J. Pharmacol, exp. Ther. 166, 14–25 (1969).
Trendelenburg, U., Hohn, D., Graefe, K.H., Pluchino, S.: The influence of block of catechol-O-methyl transferase on the sensitivity of isolated organs to catecholamines. Naunyn-Schmiede-berg’s Arch. Pharmak. 271, 59–92 (1971).
Trendelenburg, U., Maxwell, R.A., Pluchino, S.: Methoxamine as a tool to assess the importance of intraneuronal uptake of 1-norepinephrine in the cat’s nictitating membrane. J. Pharmacol, exp. Ther. 172, 91–99 (1970).
Trendelenburg, U., Muskus, A., Fleming, W.W., Gomez Alonso De La Sierra, B.: Effect of cocaine, dener-vation and decentralization on the response of the nictitating membrane to various sympathomimetic amines. J. Pharmacol, exp. Ther. 138, 181–193 (1962).
Trendelenburg, U., Weiner, N.: Sensitivity of the nictitating membrane after various procedures and agents. J. Pharmacol, exp. Ther. 136, 152–161 (1962).
Tsai, T. H.: Time course of contraction of the isolated nictitating membrane of the cat in response to 1-norepinephrine. Fed. Proc. 27, 709 (1968).
Urquilla, P.R., Stitzel, R.E., Fleming, W.W.: The antagonism of phentolamine against exogenously administered and endogenously released norepinephrine in rabbit aortic strips. J. Pharmacol, exp. Ther. 172, 310–319 (1970).
Ursillo, R.C., Jacobson, J.: Potentiation of norepinephrine in the isolated vas deferens of the rat by some CNS stimulants and antidepressants. J. Pharmacol, exp. Ther. 148, 246–251 (1965).
Van Orden, L.S., Iii, Bensch, K.G., Langer, S.Z., Trendelenburg, U.: Histochemical and fine structural aspects of the onset of denervervation supersensitivity in the nictitating membrane of the spinal cat. J. Pharmacol, exp. Ther. 157, 274–283 (1967).
Varagic, V.: The effect of isoniazide and isopropylisoniazide on the responses of the nictitating membrane of the cat to intraarterial adrenaline, noradrenaline and tyramine and to preganglionic sympathetic stimulation. Arch. int. Pharmacodyn. 114, 426–434 (1958).
Varma, D.R.: Effect of sympathetic denervation on the alpha receptors of the cat nictitating membrane. J. Pharmacol, exp. Ther. 153, 48–61 (1966).
Varma, D.R., Mccullough, H.N.: Dissociation of the supersensitivity to norepinephrine caused by cocaine from inhibition of H3norepinephrine uptake in cold-stored smooth muscle. J. Pharmacol, exp. Ther. 166, 26–34 (1969).
Verity, M.A.: Morphologic studies of vascular neuroeffector apparatus. Proc. Symp. Physiol. Pharmacol. Vase. Neuroeffector Systems, Interlaken 1969, pp. 2–12. Basel: Karger 1971.
Verity, M.A., Bevan, J.A.: Fine structural study of the terminal effector plexus, neuromuscular and intermuscular relationships in the pulmonary artery. J. Anat. (Lond.) 103, 49–63 (1968).
Wagner, K., Trendelenburg, U.: Development of degeneration contraction and supersen-sitivity in the cat’s nictitating membrane after 6-hydroxydopamine. Naunyn-Schmiede-berg’s Arch. Pharmak. 270, 215–236 (1971).
Waud, D.R.: A quantitative model for the effect of a saturable uptake on the slope of the dose-response curve. J. Pharmacol, exp. Ther. 167, 140–142 (1969).
Westfall, D.P., Fleming, W.W.: The sensitivity of the guinea-pig pacemaker to norepine-phrine and calcium after pretreatment with reserpine. J. Pharmacol, exp. Ther. 164, 259–269 (1968).
Wylie, D.W., Archer, S., Arnold, A.: Augmentation of pharmacological properties of catecholamines by O-methyl transferase inhibitors. J. Pharmacol, exp. Ther. 130, 239 to 244 (1960).
Zaimis, E.: The immunosympathectomized animal: a valuable tool in physiological and pharmacological research. J. Physiol. (Lond.) 177, 35–36P (1965).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Trendelenburg, U. (1972). Factors Influencing the Concentration of Catecholamines at the Receptors. In: Blaschko, H., Muscholl, E. (eds) Catecholamines. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65249-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-65249-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65251-6
Online ISBN: 978-3-642-65249-3
eBook Packages: Springer Book Archive